-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Non-alcoholic fatty liver is the most common liver disease in the world, accounting for about 25% of the world's population
Liver fibrosis is a strong predictor of long-term mortality in patients with non-alcoholic fatty liver
Loss of identity can lead to dysfunction
Researchers use comparative genomics to analyze the mechanisms that control the development and special functions of the most abundant cell types in the liver.
The reprogramming of liver cells is a molecular switch tightly controlled by a protein network, the so-called "transcription factor"
future career
Based on these findings, it is now possible to develop new methods to effectively target certain nodes in the protein network to prevent the progression of the disease and even reverse the existing fibrosis, which is currently impossible